Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

haploidentical natural killer cells K-NK002

A population of ex-vivo expanded and activated haploidentical donor-derived natural killer (NK) cells, with potential immunomodulating and antineoplastic activities. Upon administration prior to and following haploidentical hematopoietic cell transplantation, the haploidentical NK cells K-NK002 may induce an anti-tumor immune response and may exert cytotoxicity against tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:haploidentical NK cells K-NK002
haploidentical NKs K-NK002
NK cells K-NK002
Code name:K-NK 002
K-NK-002
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search